OVERVIEW

Journal-Based CME: MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition is organized by Memorial Sloan Kettering Cancer Center (MSKCC).

Release Date: 19-01-2023
Expired Date: 19-01-2026

Description:
This Journal-Based CME activity consists of a full-text article that is free to read, a multiple-choice question test, and an evaluation/self-assessment. Learners are tested on their comprehension of the key concepts, with the objective of enriching their clinical practice and patient care through better understanding of scientific advances and new techniques in the fields covered by Journal of Experimental Medicine (JEM).

Questions for this complimentary, online-only activity have been designed by JEM editors in collaboration with the article authors. Each CME activity should take approximately 1 hour to complete.

The article selected for this activity is “MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition,” by Mark Silvis, Dilru Silva, Martin McMahon, Conan Kinsey, and colleagues at the Huntsman Cancer Institute and University of Utah.

Objectives:
• Comprehend key points in the research findings outlined in the activity.
• Differentiate between old and new concepts.
• Learners will have the information necessary to apply the relevant points to their clinical practice.

Additional details will be posted as soon as information is available.